April 2, 2020
RegMed Investors’ (RMi) closing bell: What is not priced in?
April 1, 2020
RegMed Investors’ (RMi) closing bell: the cell/gene sector baby programs are being disregarded and tossed with the bathwater
March 31, 2020
RegMed Investors’ (RMi) closing bell: the cell/gene sector swings neutral as Q1 ends and markets collapse
March 30, 2020
RegMed Investors’ (RMi) closing bell: the cell/gene therapy sector moves to the upside and stays there
March 27, 2020
RegMed Investors’ (RMi) closing bell: volatility strikes to the heart of cell/gene therapy sector and its sentiment indicator
March 25, 2020
RegMed Investors’ (RMi) closing bell: stimulus inspires markets another 5% gain after Tuesday’s 11% incline
March 24, 2020
RegMed Investors’ (RMi) closing bell: cell and gene therapy recover as volume moves the ladder of inclines
March 23, 2020
RegMed Investors’ (RMi) closing bell: a distressed market influences the cell and gene therapy sector
March 20, 2020
RegMed Investors’ (RMi) closing bell: whiplash, fear, panic and quadruple witching fuel volatility
March 19, 2020
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector rises like the mythological phoenix
March 18, 2020
RegMed Investors’ (RMi): another liquidity scramble as volatility speeds through open lanes of resistance
March 17, 2020
RegMed Investors’ (RMi): a stressed market and sector rebounds
March 16, 2020
RegMed Investors’ (RMi): a session of dealing with unknowns and uncertainty
March 13, 2020
RegMed Investors’ (RMi): the sector carousel kept turning after dips stopped and upside motion re-started
March 12, 2020
RegMed Investors’ (RMi): the sector was surrounded by strong winds in the eye of the storm
March 11, 2020
RegMed Investors’ (RMi): Wednesday caught a falling knife
March 10, 2020
RegMed Investors’ (RMi): the velocity of valuation heads north
March 9, 2020
RegMed Investors’ (RMi): stock pricing is stuck in quicksand
March 6, 2020
RegMed Investors’ (RMi): a big blip with a moderate comeback or a black swan
March 4, 2020
RegMed Investors’ (RMi): the trend is your friend until it isn’t as the market reprices the impact of the coronavirus
March 2, 2020
RegMed Investors’ (RMi) closing bell: markets are jumping and bringing the sector along for the ride
February 28, 2020
RegMed Investors’ (RMi) closing bell: my coverage sector closed positive showing share pricing life
6 hours 2 min ago
RegMed Investors’ (RMi) closing bell: What is not priced in?
14 hours 47 min ago
RegMed Investors’ (RMi) pre-open: what’s the key word in defining a bottom, time
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2020 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.